BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 196635)

  • 1. Phospholipid-protein interactions in human low density lipoprotein detected by 31P nuclear magnetic resonance.
    Yeagle PL; Langdon RG; Martin RB
    Biochemistry; 1977 Jul; 16(15):3487-91. PubMed ID: 196635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location and interactions of phospholipid and cholesterol in human low density lipoprotein from 31P nuclear magnetic resonance.
    Yeagle PL; Martin RB; Pottenger L; Langdon RG
    Biochemistry; 1978 Jul; 17(14):2707-10. PubMed ID: 210780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-X: carbon-13 nuclear magnetic resonance studies on native, reconstituted, and model systems.
    Brainard JR; Hamilton JA; Cordes EH; Patsch JR; Gotto AM; Morrisett JD
    Biochemistry; 1980 Sep; 19(18):4266-73. PubMed ID: 7417403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 31P nuclear magnetic resonance evidence for polyphosphoinositide associated with the hydrophobic segment of glycophorin A.
    Armitage IM; Shapiro DL; Furthmayr H; Marchesi VT
    Biochemistry; 1977 Apr; 16(7):1317-20. PubMed ID: 191066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure of the lipopolysaccharide/human plasma low density lipoprotein complex. 31P-NMR and fluorescence spectroscopy studies].
    Viktorov AV; Gladkaia EM; Iurkiv VA
    Biokhimiia; 1989 Apr; 54(4):549-58. PubMed ID: 2667645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-X: proton and phosphorus-31 nuclear magnetic resonance studies on native, reconstituted, and model systems.
    Brainard JR; Cordes EH; Gotto AM; Patsch JR; Morrisett JD
    Biochemistry; 1980 Sep; 19(18):4273-9. PubMed ID: 7417404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between glycophorin and phospholipids in recombined systems.
    Romans AY; Yeagle PL; O'Connor SE; Grisham CM
    J Supramol Struct; 1979; 10(2):241-51. PubMed ID: 222968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunological study of the surface protein of the human serum low-density lipoprotein: comparison of the native particle and the products obtained by tryptic treatment.
    Goldstein S; Chapman MJ
    Biochem Biophys Res Commun; 1979 Mar; 87(1):121-7. PubMed ID: 222264
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid-protein interactions in human plasma LDL evidenced by magnetic resonance.
    Kveder M; Marinić Z; Krisko A; Vikić-Topić D; Pifat G
    Chem Phys Lipids; 2006 Jun; 141(1-2):225-9. PubMed ID: 16631150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 31P nuclear magnetic resonance studies of the phospholipid-protein interface in cell membranes.
    Yeagle PL
    Biophys J; 1982 Jan; 37(1):227-39. PubMed ID: 6120013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insoluble complex formation between low density lipoprotein and heparin. A 31P-NMR study.
    Fenske DB; Cushley RJ
    Chem Phys Lipids; 1990 Apr; 54(1):9-16. PubMed ID: 2361235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-induced changes in 31P-MRS (magnetic resonance spectroscopy) spectra of sera from patients with acute leukemia.
    Kuliszkiewicz-Janus M; Baczyński S
    Biochim Biophys Acta; 1997 Feb; 1360(1):71-83. PubMed ID: 9061042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas.
    Kuliszkiewicz-Janus M; Baczyński S
    Magn Reson Med; 1996 Apr; 35(4):449-56. PubMed ID: 8992193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR studies of pig low- and high-density serum lipoproteins. Molecular motions and morphology.
    Finer EG; Henry R; Leslie RB; Robertson RN
    Biochim Biophys Acta; 1975 Feb; 380(2):320-7. PubMed ID: 164237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composition and structure of lipopolysaccharide-human plasma low density lipoprotein complex. Analytical ultracentrifugation, 31P-NMR, ESR and fluorescence spectroscopy studies.
    Victorov AV; Medvedeva NV; Gladkaya EM; Morozkin AD; Podrez EA; Kosykh VA; Yurkiv VA
    Biochim Biophys Acta; 1989 Aug; 984(1):119-27. PubMed ID: 2548621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoproteins associated with lipoprotein B in human serum low density lipoproteins].
    Salmon S; Van Wambeke A; Theron L; Ayrault-Jarrier M; Polonovski J
    Biochim Biophys Acta; 1982 Mar; 710(3):297-305. PubMed ID: 7074118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction.
    Lund-Katz S; Laplaud PM; Phillips MC; Chapman MJ
    Biochemistry; 1998 Sep; 37(37):12867-74. PubMed ID: 9737865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis of apoproteins in human serum low density lipoprotein.
    Ikai A; Yagisawa H
    J Biochem; 1977 Apr; 81(4):955-61. PubMed ID: 195937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.